As regulatory expectations evolve and patient engagement continues to be a focal point in clinical trials, Teckro has unveiled its Patient Data Return feature. It has been designed to provide patients with easier access to their medical reports while giving sponsors enhanced oversight into engagement levels.

This latest update allows clinical trial participants to securely log in, view their assigned study documents, and share them with their healthcare providers. By integrating directly into existing site workflows, Teckro says the feature ensures that patient data is efficiently managed and accessed, while aligning with global initiatives such as the TransCelerate Participant Data Return project. This solution is one of the few globally that enables scalable patient data return with a mobile-first, intuitive design.

“Transparency in clinical trials is no longer optional—it’s an expectation,” said Gary Hughes, CEO of Teckro.

“Patients should have easy access to their data, and sponsors need better visibility into how participants engage with trials. Our new feature simplifies both, helping sites and sponsors provide a better patient experience while ensuring compliance with evolving regulations and best practices.”

Professor Brendan Buckley, chief medical officer of Teckro, added: “Participants in a clinical trial should generally be facilitated, if they wish, to access their own data captured in the trial. This bears on our basic personal right to access important data about ourselves, as well as contributing to the completeness of medical records. From a pragmatic point of view, trial participants are more likely to engage with more commitment if they feel true partnership in the study, and easy data access is a key part of this. However, the protection of highly sensitive health data is vital and is bound tightly in legislation such as HIPAA in the US and GDPR in the EU.”

He continued, “It can be difficult and expensive to provide legally compliant access for participants to their trial data. Now the company has solved this problem. With confidentiality and data protection compliance engineered in, Teckro makes it simple for participants, solely through their own investigators, to access their data while maintaining their anonymity with all other parties. This is a significant step forward in partnering with the most important people in any trial; those who honour us with their trust by being participants.”

Why this matters now

Regulatory Focus on Patient Data Return: Global regulatory bodies, including ICH E6(R3), are stressing the importance of providing patients with access to their clinical trial data, pushing sponsors to implement patient-friendly solutions.

Growing demand for digital-first clinical trials: With the UK government’s Secure Data Environments MVP launching in 2025, sponsors need to modernize their patient engagement strategies to meet transparency requirements.

Better site oversight and compliance: The company’s integrated data return process ensures that sponsors gain real-time insights into patient engagement, improving trial efficiency and maintaining data integrity.

The Patient Data Return feature, Teckro says, is designed with the participant in mind, ensuring they can easily access and understand their clinical trial data. Instead of navigating complex medical reports, patients receive content in an easy-to-understand format, which they can share with their GP or specialist. This feature, the company says, not only enhances personal health outcomes but also empowers patients to make more informed decisions about their care, strengthening trust and engagement in the trial process.

Teckro says it has already seen positive results from pilot users, with participants accessing and sharing their data to gain valuable insights, improving their health outcomes.

A proven track record in clinical trial digitization

The company currently collaborates with seven of the top 10 global pharmaceutical companies across 19,600 study sites in 79 countries. It is the only data-driven site performance solution for clinical trials, founded by the team behind Firecrest, which was acquired by ICON, a global leader in clinical research.

Teckro says sponsors report:

• Higher patient engagement, with sites experiencing up to seven times more interactions compared to traditional methods.
• Increased efficiency, reducing administrative burden for site staff through automated patient data return workflows.
• Improved retention and compliance, ensuring that participants stay informed and engaged throughout the trial.

The company says its user-centric approach has already streamlined site operations and improved study outcomes. The introduction of the Patient Data Return feature, it adds, further strengthens the relationship between sponsors, sites, and patients, making clinical trials more transparent, efficient, and patient-focused.